000 02309 a2200637 4500
005 20250515231755.0
264 0 _c20101004
008 201010s 0 0 eng d
022 _a1945-7170
024 7 _a10.1210/en.2010-0027
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGetachew, Robel
245 0 0 _aPDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL.
_h[electronic resource]
260 _bEndocrinology
_cSep 2010
300 _a4356-67 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAorta
_xdrug effects
650 0 4 _aApolipoproteins E
_xgenetics
650 0 4 _aBenzamides
650 0 4 _aBiglycan
650 0 4 _aCells, Cultured
650 0 4 _aDietary Fats
_xadministration & dosage
650 0 4 _aExtracellular Matrix Proteins
_xmetabolism
650 0 4 _aExtracellular Signal-Regulated MAP Kinases
_xmetabolism
650 0 4 _aGlycosaminoglycans
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImatinib Mesylate
650 0 4 _aLipids
_xanalysis
650 0 4 _aLipoproteins, LDL
_xmetabolism
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aMitogen-Activated Protein Kinase 1
_xmetabolism
650 0 4 _aMitogen-Activated Protein Kinase 3
_xmetabolism
650 0 4 _aMuscle, Smooth, Vascular
_xcytology
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aPlatelet-Derived Growth Factor
_xpharmacology
650 0 4 _aProtein Binding
_xdrug effects
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aProteoglycans
_xmetabolism
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aRNA Interference
650 0 4 _aReceptor, Platelet-Derived Growth Factor beta
_xgenetics
700 1 _aBallinger, Mandy L
700 1 _aBurch, Micah L
700 1 _aReid, Julianne J
700 1 _aKhachigian, Levon M
700 1 _aWight, Thomas N
700 1 _aLittle, Peter J
700 1 _aOsman, Narin
773 0 _tEndocrinology
_gvol. 151
_gno. 9
_gp. 4356-67
856 4 0 _uhttps://doi.org/10.1210/en.2010-0027
_zAvailable from publisher's website
999 _c19956713
_d19956713